Do you want to read an article? Please log in or register.
A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments
Retinal Diseases
Related content
Ultra-low-dose intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case series
Br J Ophthalmol.
Hillier RJ, Connor AJ, Shafiq AE
doi: 10.1136/bjophthalmol-
RECOMMENDED
Retinal Diseases
Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study
JAMA Ophthalmol.
Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group
doi: 10.1001/jamaophthalmol.
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study
JAMA Ophthalmol.
Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group
doi: 10.1001/jamaophthalmol.
Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity
J AAPOS.
Kennedy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group
doi: 10.1016/j.jaapos.2017.10.006.
Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology
Ophthalmology.
VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR
doi: 10.1016/
Retinal Diseases
PROGRESSIVE RETINAL DETACHMENT IN INFANTS WITH RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB
Retina.
Yonekawa Y, Wu WC, Nitulescu CE, Chan RVP, Thanos A, Thomas BJ, Todorich B, Drenser KA, Trese MT, Capone A Jr
doi: 10.1097/IAE.
Retinal Diseases
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy
JAMA Ophthalmol.
Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, Kiss S, Silva PS, Wykoff CC, Sun JK, Diabetic Retinopathy Clinical Research Network
doi: 10.1001/jamaophthalmol.
COMMENTED
Retinal Diseases
Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Ophthalmol Retina.
Hamad AE, Moinuddin O, Blair MP, Schechet SA, Shapiro MJ, Quiram PA, Mammo DA, Berrocal AM, Prakhunhungsit S, Cernichiaro-Espinosa LA, Mukai S, Yonekawa Y, Ung C, Holz ER, Harper CA 3rd, Young RC, Besirli CG, Nagiel A, Lee TC, Gupta MP, Walsh MK, Khawly JA, Campbell JP, Kychenthal A, Nudleman ED, Robinson JE, Hartnett ME, Calvo CM, Chang EY
doi: 10.1016/j.oret.2019.12.015.
Retinal Diseases
Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial
JAMA Pediatr.
Stahl A, Krohne TU, Eter N, Oberacher-Velten I, Guthoff R, Meltendorf S, Ehrt O, Aisenbrey S, Roider J, Gerding H, Jandeck C, Smith LEH, Walz JM; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group
doi: 10.1001/